In our WB analyses, renal cortical and myocardial ERK1/2 phosphorylation and Bcl-2 expression were all increased in CKD with cardiac ischemia-reperfusion after linagliptin treatment (Figs. 10 and 11). The gene discussed is MAPK3; the disease is myocardial ischemia.